Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

302
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
302
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

491
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
491
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Liver Histology01:27

Liver Histology

4.9K
The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgG4 plasma cell neoplasm in liver transplant biopsy masquerading as rejection.

Leukemia research reports·2023
Same author

Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center.

Journal of clinical and translational hepatology·2022
Same author

Author Correction: A molecular single-cell lung atlas of lethal COVID-19.

Nature·2021
Same author

Student-Authored Autopsy Reports of Anatomical Donors: Their First Patients.

Medical science educator·2021
Same author

A molecular single-cell lung atlas of lethal COVID-19.

Nature·2021
Same author

Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2020

Related Experiment Video

Updated: Mar 2, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K

Heart Disease and the Liver: Pathologic Evaluation.

Anne Knoll Koehne de Gonzalez1, Jay H Lefkowitch1

  • 1Department of Pathology and Cell Biology, Columbia University, 630 West 168th Street, PH 15 West, Rm 1574, New York, NY 10032-3725, USA.

Gastroenterology Clinics of North America
|May 17, 2017
PubMed
Summary

Acute heart failure can cause liver injury, manifesting as acute cardiogenic liver injury (ACLI) or congestive hepatopathy (CH). These conditions present distinct histological and laboratory findings, with ACLI showing necrosis and CH leading to fibrosis and cirrhosis.

Keywords:
Acute cardiogenic liver injuryCardiac cirrhosisCongestive hepatopathyFontanLiver

More Related Videos

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

7.2K
Necropsy-based Wild Fish Health Assessment
07:57

Necropsy-based Wild Fish Health Assessment

Published on: September 11, 2018

18.2K

Related Experiment Videos

Last Updated: Mar 2, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.5K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

7.2K
Necropsy-based Wild Fish Health Assessment
07:57

Necropsy-based Wild Fish Health Assessment

Published on: September 11, 2018

18.2K

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Liver injury is a known complication of acute and chronic heart failure.
  • Understanding the distinct forms of heart failure-related liver disease is crucial for patient management.

Purpose of the Study:

  • To discuss the concepts of acute cardiogenic liver injury (ACLI) and cardiac or congestive hepatopathy (CH).
  • To outline their clinical manifestations, histological findings, and potential sequelae.

Main Methods:

  • Review of existing literature on heart failure and liver injury.
  • Analysis of histological patterns and laboratory test results associated with ACLI and CH.

Main Results:

  • ACLI histologically shows centrilobular hepatocellular necrosis with elevated aminotransferases.
  • CH is characterized by centrilobular hepatocyte atrophy, sinusoidal dilation, fibrosis, and a cholestatic laboratory pattern.
  • Certain cardiac medications may contribute to liver fibrosis.

Conclusions:

  • ACLI and CH represent distinct pathophysiological processes in heart failure-related liver injury.
  • Histological and laboratory findings differentiate ACLI from CH, guiding diagnosis and prognosis.
  • Further research into medication-induced liver fibrosis in cardiac patients is warranted.